Osteoporosis Treatment Guidelines
Non-Pharmacological Interventions
- The American College of Rheumatology recommends ensuring adequate calcium intake of 1,000-1,200 mg/day through diet and supplementation if necessary 1, 2
- Vitamin D supplementation of 800 IU/day is recommended to maintain serum levels ≥20 ng/ml 1, 2, 3
- A balanced diet, smoking cessation, limitation of alcohol intake to 1-2 beverages/day, and regular weight-bearing and resistance training exercise are recommended lifestyle modifications 1, 2, 4
Pharmacological Interventions
- The American College of Rheumatology recommends oral bisphosphonates (alendronate or risedronate) as first-line therapy for osteoporosis treatment 1, 2
- Zoledronic acid (intravenous bisphosphonate) and denosumab (subcutaneous injection) are considered for patients with oral intolerance, difficulty with administration, or non-compliance 1, 2
- Anabolic agents such as teriparatide are considered for very severe osteoporosis with recent fractures or very high fracture risk 1, 2, 5
Special Considerations
- Orthogeriatric co-management is recommended for frail elderly patients with multiple comorbidities and polypharmacy 1, 6
- Early rehabilitation is crucial to regain mobility and independence after a fracture 1, 6
- Regular monitoring for medication tolerance and adherence is essential 1, 2
Monitoring and Follow-up
- Clinical fracture risk reassessment should be performed every 12 months 4
- Bone mineral density (BMD) testing should be considered every 1-3 years depending on risk factors 4, 7
- Patient education about the disease burden, risk factors, and importance of treatment adherence is critical 1, 6
Important Caveats
- Calcium supplementation alone has no demonstrated effect on fracture reduction and may be associated with gastrointestinal side effects 1, 2
- There is uncertainty whether high calcium intake is associated with cardiovascular events 1, 2
- Long-term adherence to drug treatment is often poor, necessitating systematic follow-up 1, 2
- For patients with renal impairment, medication choice may need adjustment 5, 8
- The benefits of fracture prevention must be weighed against potential medication side effects, particularly in very elderly patients 5